UK healthcare: the challenge of keeping the momentum going
This article was originally published in SRA
The year 2009 was key for the UK medical technology sector. The Kennedy Review, the Office for Life Sciences blueprint and, last month, the start-up of NICE’s Medical Technology Advisory Committee, have all built on Lord Darzi’s NHS Next Stage Review and given grounds to believe that a progressive future lies ahead. But the huge savings needed in the NHS have cast a shadow over the sector. Is it all going wrong before it has even started? asks principal analyst Ashley Yeo.
You may also be interested in...
Germany has ramped up its COVID-19 testing capacity to 260,000 per week, and still has a relatively low death rate from the virus. The country's diagnostics industry says it is ready to play its part “24/7.”
The EU Partnership on Health Innovation, a new public private health care research partnership, is in the final drafting phase before its launch under Horizon Europe. In Vivo asked the partnership’s medtech industry lead, Patrick Boisseau, to set out the innovation challenges for participants as they address unmet health care needs in Europe.
Chinese monitoring of the spread of COVID-19 locally has reported no new cases of home-grown infection in a single day for the first time since the outbreak began. It indicates control efforts, including the NMPA’s fast-tracking of relevant devices, PPE and IVDs, are having the desired effects.